Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The B cell-specific transcription factor Pax-5 has been shown previously to interact with the promoter of the
blk
gene in vitro.
blk
encodes a tyrosine kinase associated with the B cell receptor, which is expressed during the early but not the final stages of B cell development. To investigate whether Pax-5 regulates expression of the
blk
gene in vivo during B cell development and/or activation, Pax-5a was overexpressed in B cell lines. Increases in
blk
promoter activity using a chloramphenicol acetyltransferase reporter gene system suggested a role for Pax-5a as a
transcriptional activator
. Subsequent site-specific mutagenesis studies showed that mutations of the Pax-5 binding site on
blk
significantly alter promoter activity, although results suggested that other factors could bind to this region as well. Using mobility shift assays, we detected an inducible transcription factor that interacts strongly with a sequence overlapping the Pax-5 site on the
blk
promoter and identified this as a homodimer of NF-kappaB/p50, a member of the NF-kappaB/Rel family of transcription factors. This factor was present at high levels in lipopolysaccharide-activated normal B cells and in plasma cell lines but either at low levels or undetectable levels in resting normal B cells or pre-B or mature B cell lines. In contrast, lipopolysaccharide induction of a pre-B cell line (703/Z) induced a complex that contained both NF-kappaB/p50 and p65. These studies suggest that different NF-kappaB complexes are able to interact with a sequence overlapping the Pax-5 site on the
blk
promoter and that the relative levels of "bound" factor influence levels of
blk
expression. Since p50 homodimers and p50/p65 heterodimers of the NF-kappaB complex should have opposing effects on
blk
transcription, this could provide a mechanism to differentially regulate
blk
expression during B cell development and activation.
...
PMID:The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation. 966 Aug 39